Hostname: page-component-848d4c4894-tn8tq Total loading time: 0 Render date: 2024-07-02T02:31:57.610Z Has data issue: false hasContentIssue false
  • English
  • Français

Inhibition of neuronal nitric oxide synthase reduces the propofol requirements in wild-type and nNOS knockout mice

Published online by Cambridge University Press:  24 January 2006

T. Engelhardt ,
P. R. Lowe ,
H. F. Galley  and
N. R. Webster
T. Engelhardt
Affiliation:
University of Aberdeen, Academic Unit of Anaesthesia and Intensive Care, School of Medicine and Life Sciences, Scotland, UK
P. R. Lowe
Affiliation:
University of Aberdeen, Academic Unit of Anaesthesia and Intensive Care, School of Medicine and Life Sciences, Scotland, UK
H. F. Galley
Affiliation:
University of Aberdeen, Academic Unit of Anaesthesia and Intensive Care, School of Medicine and Life Sciences, Scotland, UK
N. R. Webster
Affiliation:
University of Aberdeen, Academic Unit of Anaesthesia and Intensive Care, School of Medicine and Life Sciences, Scotland, UK
Get access

Extract

Summary

Background and objective: The glutamate-nitric oxide-cyclic guanosine monophosphate pathway has been identified as a potential target for anaesthetic agents. However, mice deficient in neuronal nitric oxide synthase have a similar susceptibility to volatile anaesthetic agents to wild-type mice and are not affected by non-isoform selective inhibitors. We hypothesized that the neuronal nitric oxide synthase selective inhibitor, 7-nitroindazole, would also reduce the propofol requirements in wild-type mice but would have no effect in neuronal nitric oxide synthase knockout mice. Methods: We determined the time to loss of righting reflex, time to painful stimulus and time to regaining the righting reflex in neuronal nitric oxide synthase knockout and wild-type mice following the intraperitoneal injection of propofol in untreated, 7-nitroindazole and vehicle only treated animals (n = 6 per group). Propofol (200 mg kg−1) resulted in loss of righting reflex in the untreated and vehicle only groups but was lethal in 7-nitroindazole pre-treated mice, requiring a reduced dose of propofol (100 mg kg−1). Results: 7-nitroindazole pre-treatment significantly reduced the loss of righting reflex (P < 0.001) in both wild-type and knockout mice when compared to untreated and vehicle only pre-treated animals, but had no effect on time to painful stimulus or regaining of the righting reflex. 7-nitroindazole reduced the propofol requirements in knockout mice to the same extent as in wild-type animals. Conclusions: Propofol exerts its anaesthetic effects at least partially via the glutamate-nitric oxide-cyclic guanosine monophosphate pathway. The neuronal nitric oxide synthase knockout mice are sensitive to neuronal nitric oxide synthase selective inhibition suggesting that compensatory pathways in neuronal nitric oxide synthase knockout mice exist.

Keywords

ANESTHETICS, INTRAVENOUS propofolANIMALS miceNITRIC OXIDENUCLEOTIDES cyclic GMP
Type
Original Article
Information
European Journal of Anaesthesiology , Volume 23 , Issue 3 , March 2006 , pp. 197 - 201
Copyright
© 2006 European Society of Anaesthesiology

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Johns RA, Moscicki JC, DiFazio CA. Nitric oxide synthase inhibitor dose-dependently and reversibly reduces the threshold for halothane anesthesia. A role for nitric oxide in mediating consciousness? Anesthesiol 1992; 77: 779–784.Google Scholar
Ichinose F, Huang PL, Zapol WM. Effects of targeted neuronal nitric oxide synthase gene disruption and NG-l-arginine methylester (l-NAME) on the threshold for isoflurane anesthesia. Anesthesiol 1995; 83: 101–108.Google Scholar
Ichinose F, Mi WD, Miyazaki M, Onouchi T, Goto T, Morita S. Lack of correlation between the reduction of sevoflurane MAC and the cerebellar cyclic GMP concentrations in mice treated with 7-nitroindazole. Anesthesiol 1998; 89: 143–148.Google Scholar
Fukuda T, Saito S, Sato S et al. Halothane minimum alveolar anesthetic concentration and neuronal nitric oxide synthase activity of the dorsal horn and the locus ceruleus in rats. Anesth Analg 1999; 89: 1035–1039.Google Scholar
Kobayashi S, Katoh T, Iwamoto T, Bito H, Sato S. Effect of the neuronal nitric oxide synthase inhibitor 7-nitroindazole on the righting reflex ED50 and minimum alveolar concentration during sevoflurane anaesthesia in rats. Eur J Anaesthesiol 2003; 20: 212–219.Google Scholar
Huang PL, Dawson TM, Bredt DS, Snyder SH, Fishman MC. Targeted disruption of the neuronal nitric oxide synthase gene. Cell 1993; 75: 1273–1286.Google Scholar
Eliasson MJL, Blackshaw S, Schell MJ, Snyder SH. Neuronal nitric oxide synthase alternatively spliced forms: prominent functional localizations in the brain. Proc Natl Acad Sci USA 1997; 94: 3396–3401.Google Scholar
Putzke J, Seidel B, Huang PL, Wolf G. Differential expression of alternatively spliced isoforms of neuronal nitric oxide synthase (nNOS) and N-methyl-d-aspartate receptors (NMDAR) in knockout mice deficient in nNOSα (nNOSαΔ/Δ mice). Mol Brain Res 2000; 85: 13–23.Google Scholar
Pajewski TN, DiFazio CA, Moscicki JC, Johns RA. Nitric oxide synthase inhibitors, 7-nitro indazole and NG-l-arginine methylester (l-NAME), dose dependently reduce the threshold for isoflurane anesthesia. Anesthesiol 1996; 85: 1111–1119.Google Scholar
Irifune M, Sugimura M, Takarada T et al. Propofol anaesthesia in mice is potentiated by muscimol and reversed by bicuculline. Br J Anaesth 1999; 83: 665–667.Google Scholar
Adachi T, Kurata J, Nakao S et al. Nitric oxide synthase inhibitor does not reduce minimum alveolar anesthetic concentration of halothane in rats. Anesth Analg 1994; 78: 1154–1157.Google Scholar
Adachi T, Shinomura T, Nakao S et al. Chronic treatment with nitric oxide synthase (NOS) inhibitor profoundly reduces cerebellar NOS activity and cyclic guanosine monophosphate but does not modify minimum alveolar anesthetic concentration. Anesth Analg 1995; 81: 862–865.Google Scholar
Klatt P, Schmidt K, Brunner F, Mayer B. Inhibitors of brain nitric oxide synthase. Binding kinetics, metabolism, and enzyme inactivation. J Biol Chem 1994; 269: 1674–1680.Google Scholar
Klatt P, Schmid M, Leopold E, Schmidt K, Werner ER, Mayer B. The pteridine binding site of brain nitric oxide synthase. Tetrahydrobiopterin binding kinetics, specificity, and allosteric interaction with the substrate domain. J Biol Chem 1994; 269: 13861–13866.Google Scholar
Alderton WK, Cooper CE, Knowles RG. Nitric oxide synthase: structure, function and inhibition. Biochem J 2001; 357: 593–615.Google Scholar
Moore PK, Babbedge RC, Wallace P, Gaffen ZA, Hart SL. 7-Nitro indazole, an inhibitor of nitric oxide synthase, exhibits anti-nociceptive activity in the mouse without increasing blood pressure. Br J Pharmacol 1993; 108: 296–297.Google Scholar
Yoshida T, Limmroth V, Irikura K, Moskowitz MA. The NOS inhibitor, 7-nitroindazole, decreases focal infarct volume but not the response to topical acetylcholine in pial vessels. J Cereb Blood Flow Metab 1994; 14: 924–929.Google Scholar
Simpson VJ, Rikke BA, Costello JM, Corley R, Johnson TE. Identification of a genetic region in mice that specifies sensitivity to propofol. Anesthesiol 1998; 88: 379–389.Google Scholar
Barañano DE, Snyder SH. Neural roles for heme oxygenase: contrast to nitric oxide synthase. Proc Natl Acad Sci USA 2001; 98: 10996–11002.Google Scholar
Erden BF, Ulak G, Yildiran G, Gacar N. The effect of 7-nitro indazole on pentobarbital-induced sleep in mice. Pharmacol Res 1997; 36: 265–267.Google Scholar